Antiparasitic formulations containing avermectin and di-glycol monomethyl ether

摘要

A long-acting antiparasitic formulation suitable for topical application is disclosed, which comprises: (a) 0.1-50 % w/v an avermectin or milbemycin selected from ivermectin, doramectin, abamectin, moxidectin; (b) 1-50 % v/v a di(C2-4 glycol) mono(C1-4 alkyl) ether; (c) an optional antioxidant; and (d) an optional skin acceptable volatile solvent q.s. v/v. (62) Divided Out of 526372